Information  X 
Enter a valid email address

Allergy Therapeutics (AGY)

  Print      Mail a friend

Friday 30 March, 2012

Allergy Therapeutics

Grant of Options

RNS Number : 4166A
Allergy Therapeutics PLC
30 March 2012

30 March 2012



Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")



Grant of Options


Allergy Therapeutics plc (AIM: AGY) announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 30 March 2012 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:



Number of provisional shares awarded

Date of distribution

Total provisional shares held under LTIPs

Manuel Llobet


30 March 2012


Ian Postlethwaite


30 March 2012



The distribution of these ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the next three years.






For further information


Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer

Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw



This information is provided by RNS
The company news service from the London Stock Exchange